Effect of taurine on prostate-specific antigen level and migration in human prostate cancer cells

Adv Exp Med Biol. 2015:803:203-14. doi: 10.1007/978-3-319-15126-7_18.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Cell Movement / drug effects*
  • Cell Survival / drug effects
  • Dose-Response Relationship, Drug
  • Humans
  • Male
  • Matrix Metalloproteinase 9 / metabolism
  • Prostate-Specific Antigen / metabolism*
  • Prostatic Neoplasms / metabolism*
  • Prostatic Neoplasms / pathology*
  • Taurine / pharmacology*
  • Tissue Inhibitor of Metalloproteinase-1 / metabolism
  • Tissue Inhibitor of Metalloproteinase-2 / metabolism
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • TIMP1 protein, human
  • TIMP2 protein, human
  • Tissue Inhibitor of Metalloproteinase-1
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Tissue Inhibitor of Metalloproteinase-2
  • Taurine
  • Prostate-Specific Antigen
  • MMP9 protein, human
  • Matrix Metalloproteinase 9